88 related articles for article (PubMed ID: 1465322)
1. [Comparison between the use of anti-secretory-component (sc) antibodies and anti-mucin-like-cancer-antigen (MCA) antibodies in the identification of cancer cells in serous effusions].
Morea F; L'Abbate A
Pathologica; 1992; 84(1091):371-6. PubMed ID: 1465322
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical identification of secretory component (SC) in activated mesothelial cells].
Morea F; Albrizio M; L'Abbate A
Pathologica; 1993; 85(1100):729-32. PubMed ID: 8170721
[TBL] [Abstract][Full Text] [Related]
3. [Identification of mucin-secretion characteristics in cells from serous effusions: consideration of histochemical and immunohistochemical aspects].
Morea F; L'Abbate A; Albrizio M
Pathologica; 1991; 83(1083):119-25. PubMed ID: 1866195
[TBL] [Abstract][Full Text] [Related]
4. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
5. Mucin glycoproteins as tumor markers.
Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
[TBL] [Abstract][Full Text] [Related]
6. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
[TBL] [Abstract][Full Text] [Related]
7. MCA performance in preoperative breast cancer patients.
Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
Brown JP; Linsley PS; Horn D
Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
[No Abstract] [Full Text] [Related]
9. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
Flynn MK; Johnston W; Bigner S
Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
[TBL] [Abstract][Full Text] [Related]
11. Performance of the mucinous-like carcinoma-associated antigen in serous effusions.
Cappellari A; Bagarella M; Olivati S; Corradi G
Oncology; 1992; 49(5):354-7. PubMed ID: 1528570
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
13. Mucin-like carcinoma-associated antigen defined by three monoclonal antibodies against different epitopes.
Stähli C; Caravatti M; Aeschbacher M; Kocyba C; Takacs B; Carmann H
Cancer Res; 1988 Dec; 48(23):6799-802. PubMed ID: 2460229
[TBL] [Abstract][Full Text] [Related]
14. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
15. Heritable variation in expression of multiple tumor associated epitopes on a high molecular weight mucin-like antigen.
Linsley PS; Ochs V; Horn D; Ring DB; Frankel AE
Cancer Res; 1986 Dec; 46(12 Pt 1):6380-6. PubMed ID: 2430697
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mucinous-like cancer antigen (MCA) in women with breast disease: preliminary results.
Valenti G; Zanardi S; Valtolina M; Bombardieri E; Boccardo F
Cancer Detect Prev; 1991; 15(4):285-9. PubMed ID: 1794135
[TBL] [Abstract][Full Text] [Related]
17. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: a follow-up and comparative investigation.
Jensen ML; Johansen P
Diagn Cytopathol; 1996 Jul; 15(1):33-6. PubMed ID: 8807249
[TBL] [Abstract][Full Text] [Related]
20. Characterization of epitopes of human secretory component on free secretory component, secretory IgA, and membrane-associated secretory component.
Woodard CS; Splawski JB; Goldblum RM; Denney RM
J Immunol; 1984 Oct; 133(4):2116-25. PubMed ID: 6206152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
